In the News

The U.S. National Institutes of Health support diabetes research at the IRCM
By IRCM
August 26, 2015

A Canadian research team working on the development of an external artificial pancreas is receiving a grant of $2,509,367 USD from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the U.S. National Institutes of Health (NIH).

Read More
ViaCyte Announces Highly Anticipated Encapsulation Clinical Trial Site Expansion into Canada
By JDRF Canada
July 29, 2015

ViaCyte, Inc. announced the opening of a second site in its Phase 1/2 trial called STEP ONE, or Safety, Tolerability and Efficacy of VC-01™ Combination Product in Type One Diabetes (T1D), at the University of Alberta Hospital in Edmonton, Alberta funded in part by the JDRF Canadian Clinical Trial Network (CCTN).

Read More
MUHC conducts first islet cell transplant in Quebec
By McGill University
July 24, 2015

Innovative treatment for type 1 diabetes marks first step towards vision of regional network for islet cell isolation and transplant 

Read More
JDRF-Supported Researchers Make Gains in Designing Islet Cell Encapsulation Materials for Use in Type 1 Diabetes Therapies
By JDRF Canada
June 15, 2015

New study shows size and shape of encapsulation materials have an effect on islet cell survival

Read More
BD and Medtronic Collaborate to Introduce a New Infusion Set with BD FlowSmart Technology Designed to Improve Insulin Pump Therapy
By JDRF Canada
June 8, 2015

BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Medtronic (NYSE: MDT) today announced a collaboration to introduce a new insulin pump infusion set with BD FlowSmart™ technology​

Read More